CannaPharmaRX

(OTC) CPMD

Current Price$0.00

Market Cap$475.00K

Since IPO (1999)-100%

5 Year-99%

1 Year-83%

1 Month-82%

CannaPharmaRX Financials at a Glance

Market Cap

$475.00K

Revenue (TTM)

$1.65M

Net Income (TTM)

-$10.82M

EPS (TTM)

-$0.02

P/E Ratio

-0.04

Dividend

$0.00

Beta (Volatility)

-919.29 (Low)

Dividend

$0.00

Beta (Volatility)

-919.29 (Low)

Price

$0.00

Volume

798,180

Open

$0.00

Price

$0.00

Volume

798,180

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Nov 14, 2025

Dividend

$0.00

Beta (Volatility)

-919.29 (Low)

Price

$0.00

Volume

798,180

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Nov 14, 2025

CPMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CannaPharmaRX

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Constantine Nkafu

Website

www.cannapharmarx.com

Headquarters

Calgary, AB T2P 5C5, CA

CPMD Financials

Key Financial Metrics (TTM)

Gross Margin

-1%

Operating Margin

-2%

Net Income Margin

-7%

Return on Equity

Return on Capital

13%

Return on Assets

-2%

Earnings Yield

-25.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$475.00K

Shares Outstanding

678.50M

Volume

798.18K

Avg. Volume

179.66K

Financials (TTM)

Gross Profit

-$2.08M

Operating Income

-$3.35M

EBITDA

-$8.68M

Operating Cash Flow

-$789.10K

Capital Expenditure

-$5.52K

Free Cash Flow

-$794.62K

Cash & ST Invst.

$1.80K

Total Debt

$20.65M

CannaPharmaRX Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$627.46K

+87.1%

Gross Profit

-$409.45K

+18.6%

Gross Margin

-65.26%

N/A

Market Cap

$475.00K

N/A

Market Cap/Employee

$18.27K

N/A

Employees

N/A

Net Income

-$382.02K

+44.7%

EBITDA

-$682.34K

-1277.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$633.00

-47.6%

Total Debt

$20.97M

+25.1%

Accounts Receivable

$26.01K

-90.9%

Inventory

$902.91K

-5.1%

Long Term Debt

$5.36M

+10.6%

Short Term Debt

$15.61M

+31.0%

Return on Assets

-1.64%

N/A

Return on Invested Capital

13.46%

N/A

Free Cash Flow

-$243.66K

+59.5%

Operating Cash Flow

-$243.66K

+59.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LVVEFYooma Wellness Inc.

LVVEFYooma Wellness Inc.$0.00+0.00%

PLSHPanacea Life Sciences Holdings, Inc.

PLSHPanacea Life Sciences Holdings, Inc.$0.03+0.00%

MJARFMJardin Group, Inc.

MJARFMJardin Group, Inc.$0.00+0.00%

ALIDAllied Corp.

ALIDAllied Corp.$0.00+0.00%

CBDYTarget Group Inc.

CBDYTarget Group Inc.$0.00+0.00%

SRUTFSproutly Canada Inc.

SRUTFSproutly Canada Inc.$0.00+0.00%

APPBApplied Biosciences Corp.

APPBApplied Biosciences Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.59+0.01%

Questions About CPMD

What is the current price of CannaPharmaRX?

CannaPharmaRX is trading at $0.00 per share.

What is the 52-week range for CannaPharmaRX?

Over the past 52 weeks, CannaPharmaRX has traded between $0.00 and $0.01.

How much debt does CannaPharmaRX have?

As of the most recent reporting period, CannaPharmaRX reported total debt of $20.97M.

How much cash does CannaPharmaRX have on hand?

CannaPharmaRX reported $633.00 in cash and cash equivalents in its most recent financial results.

What is CannaPharmaRX’s dividend yield?

CannaPharmaRX does not currently have a dividend yield.

CannaPharmaRX

CannaPharmaRX Financials at a Glance

CPMD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About CannaPharmaRX

CPMD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

CannaPharmaRX Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CPMD

What is the current price of CannaPharmaRX?

What is the 52-week range for CannaPharmaRX?

How much debt does CannaPharmaRX have?

How much cash does CannaPharmaRX have on hand?

What is CannaPharmaRX’s dividend yield?

Premium Investing Services